In reply: the evaluation of IgG titers' stability from blood samples is necessary
- PMID: 32100489
- PMCID: PMC7044011
- DOI: 10.3802/jgo.2020.31.e44
In reply: the evaluation of IgG titers' stability from blood samples is necessary
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Comment on
-
A phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3.J Gynecol Oncol. 2019 Nov;30(6):e88. doi: 10.3802/jgo.2019.30.e88. J Gynecol Oncol. 2019. PMID: 31576684 Free PMC article. Clinical Trial.
-
Comments on: a phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3.J Gynecol Oncol. 2020 Mar;31(2):e43. doi: 10.3802/jgo.2020.31.e43. J Gynecol Oncol. 2020. PMID: 32100488 Free PMC article. No abstract available.
Similar articles
-
Serological responses to human papillomavirus type 6 and 16 virus-like particles in patients with cervical neoplastic lesions.Clin Diagn Lab Immunol. 1996 Jul;3(4):403-10. doi: 10.1128/cdli.3.4.403-410.1996. Clin Diagn Lab Immunol. 1996. PMID: 8807204 Free PMC article.
-
Immunoglobulin concentrations in cervical mucus in patients with normal and abnormal cervical cytology.Br J Obstet Gynaecol. 1977 Feb;84(2):129-34. doi: 10.1111/j.1471-0528.1977.tb12539.x. Br J Obstet Gynaecol. 1977. PMID: 843479
-
In Reply.Obstet Gynecol. 2016 Jan;127(1):163. doi: 10.1097/AOG.0000000000001223. Obstet Gynecol. 2016. PMID: 26695568 No abstract available.
-
Cervical cancer, human papillomavirus and vaccines.Clin Oncol (R Coll Radiol). 1993;5(6):386-90. doi: 10.1016/s0936-6555(05)80093-7. Clin Oncol (R Coll Radiol). 1993. PMID: 8305362 Review.
-
Prevention of human papilloma virus infection with vaccines.J Pak Med Assoc. 2010 Aug;60(8):676-81. J Pak Med Assoc. 2010. PMID: 20726203 Review.
References
-
- Kawana K, Adachi K, Kojima S, Taguchi A, Tomio K, Yamashita A, et al. Oral vaccination against HPV E7 for treatment of cervical intraepithelial neoplasia grade 3 (CIN3) elicits E7-specific mucosal immunity in the cervix of CIN3 patients. Vaccine. 2019;32:6233–6239. - PubMed
-
- Adachi K, Kawana K, Yokoyama T, Fujii T, Tomio A, Miura S, et al. Oral immunization with a Lactobacillus casei vaccine expressing human papillomavirus (HPV) type 16 E7 is an effective strategy to induce mucosal cytotoxic lymphocytes against HPV16 E7. Vaccine. 2010;28:2810–2817. - PubMed
-
- Gonçalves AK, Machado PR, de Souza, LC, Costa AP, Gimenes F, Consolaro ML, et al. Detection of immunoglobulin IgA and IgG against human papilloma virus. Viral Immunol. 2014;27:471–477. - PubMed